BioLife Solutions Inc
NASDAQ:BLFS

Watchlist Manager
BioLife Solutions Inc Logo
BioLife Solutions Inc
NASDAQ:BLFS
Watchlist
Price: 24.86 USD -0.36% Market Closed
Market Cap: 1.2B USD

Relative Value

The Relative Value of one BLFS stock under the Base Case scenario is 8.42 USD. Compared to the current market price of 24.86 USD, BioLife Solutions Inc is Overvalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLFS Relative Value
Base Case
8.42 USD
Overvaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
8
Median 3Y
9.4
Median 5Y
10.7
Industry
2.4
Forward
12
vs History
vs Industry
1
Median 3Y
-14.7
Median 5Y
-13
Industry
22.9
Forward
-71.8
vs History
31
vs Industry
1
Median 3Y
-57.3
Median 5Y
-57.3
Industry
14.7
vs History
vs Industry
Median 3Y
-107.5
Median 5Y
-102.8
Industry
21.4
vs History
34
vs Industry
24
Median 3Y
2.9
Median 5Y
3
Industry
2.3
vs History
28
vs Industry
9
Median 3Y
9.2
Median 5Y
10
Industry
2.6
Forward
11.2
vs History
63
vs Industry
9
Median 3Y
18
Median 5Y
19.1
Industry
5.3
vs History
20
vs Industry
0
Median 3Y
-22.9
Median 5Y
-22.6
Industry
12.3
Forward
46.4
vs History
vs Industry
Median 3Y
-34
Median 5Y
-28
Industry
17.2
Forward
-57.1
vs History
30
vs Industry
2
Median 3Y
-55.3
Median 5Y
-56.6
Industry
15
vs History
vs Industry
1
Median 3Y
-34
Median 5Y
-41
Industry
19
vs History
30
vs Industry
21
Median 3Y
2.8
Median 5Y
3.1
Industry
1.9

Multiples Across Competitors

BLFS Competitors Multiples
BioLife Solutions Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
BioLife Solutions Inc
NASDAQ:BLFS
1.2B USD 13.4 -371.9 233.8 -1 067.6
JP
Hoya Corp
TSE:7741
8.5T JPY 9.5 40.6 25.2 30.1
CH
Alcon AG
SIX:ALC
31.5B CHF 3.9 37.6 15.7 30.6
DK
Coloplast A/S
CSE:COLO B
127.6B DKK 4.6 35.1 16.1 19.1
US
Align Technology Inc
NASDAQ:ALGN
12.4B USD 3.1 32.9 14.9 18.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
49.4B CNY 10.9 29.9 27.5 27.5
UK
ConvaTec Group PLC
LSE:CTEC
5B GBP 2.9 31.2 224.8 365.3
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD 1.2 -20 19.7 93.1
CH
Ypsomed Holding AG
SIX:YPSN
4.7B CHF 6 24.3 15.8 21.4
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.1B USD 3.5 43.2 19.6 32.7
JP
Asahi Intecc Co Ltd
TSE:7747
796.3B JPY 6.4 52.5 23.1 33.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
BioLife Solutions Inc
NASDAQ:BLFS
Average EV/EBIT: 67.2
Negative Multiple: -1 067.6
N/A N/A
JP
Hoya Corp
TSE:7741
30.1
N/A N/A
CH
Alcon AG
SIX:ALC
30.6
23%
1.3
DK
Coloplast A/S
CSE:COLO B
19.1
8%
2.4
US
Align Technology Inc
NASDAQ:ALGN
18.9
15%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.5
11%
2.5
UK
ConvaTec Group PLC
LSE:CTEC
365.3
22%
16.6
CA
Bausch + Lomb Corp
NYSE:BLCO
93.1
60%
1.6
CH
Ypsomed Holding AG
SIX:YPSN
21.4
29%
0.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
32.7
30%
1.1
JP
A
Asahi Intecc Co Ltd
TSE:7747
33.6
N/A N/A